South Africa’s health products regulator, Sahpra, has withheld approval for Russia’s Sputnik V Covid vaccine over concerns that it could increase the risk of HIV infection among men.
The decision was based on two earlier studies that tested the safety of a modified form of adenovirus contained in the Russian jab.
The Gamaleya Institute, which developed Sputnik V, says it would produce information to show that Sahpra's concerns were completely unfounded.
Sahpra says its concerns followed consultations with local and international experts.
South Africa’s health products regulator, Sahpra, has withheld approval for Russia’s Sputnik V Covid vaccine over concerns that it could increase the risk of HIV infection among men.
The decision was based on two earlier studies that tested the safety of a modified form of adenovirus contained in the Russian jab.
The Gamaleya Institute, which developed Sputnik V, says it would produce information to show that Sahpra's concerns were completely unfounded.
Sahpra says its concerns followed consultations with local and international experts.
read more
read less
